Status of Non-Classical Mononuclear Platinum Anticancer Drug Development

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|9|11|1357-1366

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.9, Iss.11, 2009-10, pp. : 1357-1366

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development and Current Status of Unconventional Platinum Anticancer Complexes

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 2, 2007-01 ,pp. : 203-211

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Classical Structures Among Current Platinum Complexes with Potential as Antitumor Drugs

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 21, 2011-11 ,pp. : 2613-2622

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Approaches Towards Development of Non-Classical Platinum-Based Antineoplastic Agents: Design of Platinum Complexes Characterized by an Alternative DNA-Binding Pattern and/or Tumor-Targeted Cytotoxicity

By  

Current Medicinal Chemistry, Vol. 12, Iss. 19, 2005-09 ,pp. : 2177-2191

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Classical Drug Metabolism Enzymes: The Curious Case of Phenylalanine 4-Monooxygenase

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 6, 2006-08 ,pp. : 405-412

Bentham Science Publishers

Access to resources Recommend Favorite

Interactions of Cisplatin with non-DNA Targets and their Influence on Anticancer Activity and Drug Toxicity: The Complex World of the Platinum Complex

By  

Current Cancer Drug Targets, Vol. 14, Iss. 9, 2014-01 ,pp. : 794-816

Bentham Science Publishers

Access to resources Recommend Favorite